Bleeding Disorders HOPE Maram Al-anbar

Size: px
Start display at page:

Download "Bleeding Disorders HOPE Maram Al-anbar"

Transcription

1 Bleeding Disorders HOPE Maram Al-anbar

2 ^^ Attention Please ^^ We ( correction team of pediatric package^hope/2010^ ) had decided to make one lecture of bleeding disorders in place of the two lectures we had in our package Including the content of the previous lectures Plus other sources to make it one organized lec. Hoping for you to get the most benefit,, study easily,, and not getting distracted or bothering yourself looking at other sources the sources of this lecture are : Previous 2 lectures + Nelson + Pediatric in Page + some youtube videos... Soo.. Let s begin our lecture,, Shall We ^^ ** NORMAL HOMEOSTASIS ** it s a dynamic process that occur in area of VASCULAR INJURY composed of :: *platelets *vascular wall *procoagulant proteins * anticoagulant proteins Now.. What is the sequence of events that occur in this process?!! Once there is injury to the vascular endothelium what happens?? :: 1* Vasoconstriction.. 2* Primary Homeostatic mechanism (platelet plug formation).. 3* Secondary Homeostatic mechanism (fibrin clot,, thrombus).. 4* Anti thrombotic and Fibrinolytic events.. It starts with injury to vascular endothelium exposure of subendothelial collagen confrontational changes in vwf (von-willebrand factor) platelets bind to vwf via their receptor GPIb in a process called ADHESION then these platelets get activated and produce substances ex. ADP that recruit other platelets from circulation to come then platelets bind with each other in layers using their receptors GPIIb-IIIa using fibrinogen as a ligand between the receptors in a process called AGGREGATION 1

3 forming in the end Primary Homeostatic Plug ( Platelet Plug ) that will temporally stop the bleeding,, Soo... **Adhesion is : Platelet - Subendothelial Interaction (GP-Ib _vwf) **Aggregation is : Platelet - Platelet Interaction ( GPIIb/IIIa _ fibrinogen_gpiib/iiia ) ** Then comes the Secondary Homeostatic mechanism that totally aims at the process of conversion of FIBRINOGEN into FIBRIN ( remember the fibrinogen that served as a ligand between platelets in the plug now we want to convert it into fibrin and organize it in a strong & stable network (clot) that permanently stop the bleeding ),, and this is done by what s called COAGULATION CASCADE and this cascade has two pathways :: 2

4 ** EXTRINSIC ** ** INTRINSIC ** Shorter pathway.. Longer pathway.. Starts with factor 7.. Starts with factor 12.. Stimulated with tissue factor as a result of trauma to the vessel.. Stimulated with inflammatory mediator as a result of inflammation.. The pathway is 7 10* (in presence of activated F8 + Ca + PF) 10* *At F10 starts the common pathway 10(in presence of activated F5 + Ca + PF) 2 1 details below WARFARIN can block this pathway (inhibiting the production of vit.k dependent factors -10,9,7,2- by inhibiting the activation of vit.k.. Measured by PT/ INR tests.. HEPARIN can block this pathway (stimulating antithrombine III that inhibits thrombin(f2) & factors -11,10,9-.. Measured by aptt test.. Cascade means in a step wise manner where the active form of the factor acts as an Enzyme,, where as the inactive form acts as a Substrate Ex. FXIIa act as an enzyme,, FXI act as a substrate... أفضل تعريف لذاتك أنك لست أفضل من أحد ولست كأي أحد ولست أقل من أحد... 3

5 Now how this cascade occur?!! Let s take the Intrinsic pathway :: 1 st we have inflammatory mediator that activates FXII from inactive into active form FXIIa XII XIIa (then this will activates XI) XI XIa(then this activates IX) IX IXa (then this with VIIIa +Ca +PF activates X ) X Xa (then this with Va +Ca +PF activates prothrimbin II into thrombin IIa ) II IIa(here thombin convert fibrinogen I into FIBRIN I * the final product that we need ) I Ia NOW fibrin Ia is stabilized with FXIII for clot formation ^^ 4

6 Now let s talk about thrombin and the imp. Functions that performs :: 1* conversion of fibrinogen into FIBRIN.. 2* activation of FXIII( fibrin stabilizing factor ) that will bind fibrin and stabilize it into a CLOT.. 3* act as platelet AGONIST ( attracts more and more platelets ).. 4* activates plasminogen into PLASMIN ( which is fibrinolytic enzyme ) 5* activates factors V, VIII, XI.. ** Imp Note all coagulation factors are made in the liver except FVIII made in vascular endothelium and bound with vwf ** another Note : Deficiency of FVIII, FIX lead to sever bleeding disorder Deficiency of FXI lead to mild bleeding disorder Deficiency of FXII is asymptomatic AND the last stage after the thrombus(clot) has been formed and the bleeding has been stopped now we want to : ** prevent further thrombotic events by anti thrombotic enzymes ex. Anti-thrombin III,, protein C,, protein S... ** Dissolve the thrombus and resume the blood flow by fibrinolytic enzymes ex. Plasmin.. 5

7 Soo we ve just finished the normal process of homeostasis ^^hoping that it was clear enough so that we start with the imp. part of the lec. :: BLEEDING DISORDERS :: They can be classified into : 1- Platelet disorders.. 2- Coagulation disorders.. 3- Blood vessel disorders : ** Congenital ex. Ehler-danlos Syndrome,, Osler-Weber-Rendu Syndrome.. **Acquired ex. Senile Purpura,, HSP (henoch schoenlein purpura ).. 6

8 Clinical presentation :: ** superficial bleeding ** in 1-skin in form of *petechia(pinpoint rash <3mm),, *purpura(adjoining petechia 3-10mm),, *ecchymosis( >1cm).. 2-mucous membranes as in epistaxis,, menorrhagia.. ** Immediate bleeding ** immediately after injury.. Lab tests we order :: 1- Platelet count (CBC) : NL ( )x1000/microL.. 2- Bleeding time (time needed for bleeding to stop) NL 3-10 minutes.. Platelets disorders Can be classified into :: Qualitative disorders where the platelet count is normal but abnormal function :: ** Inherited : 1- Bernard soulier syndrome (BS).. 2- Glanzmann thrombasthenia (GT).. 3- von-willebrand disease (vwd).. ** acquired : 1- Uremia (renal failure ).. 2- Aspirin.. 3- Alcohol.. Quantitative disorders where the platelet count is low ( thrombocytopenia ) :: ** Decreased marrow production : 1- Aplastic Anemia.. 2- BM infiltration ex. Leukemia.. ** Excess Destruction : 1- ITP ( idiopathic thrombocytopenic purpura ) 2- TTP ( thrombotic thrombocytopenic purpura ) 3- HUS ( hemolytic uremic syndrome ) 4- DIC ( disseminated Intravascular Coagulopathy ) 5- HIT ( heparin induced thrombocytopenia ) ** Sequestration :Hypersplenism.. 7

9 Now let s talk about some of the Quantitative disorders :: >> I stands for : **Idiopathic ( unknown reason ) **Immune ( involvement of auto antibodies) **Isolated ( cuz only Thrombocytopenia is present No Anemia,, No Leukopenia ) >> T stands for Thrombocytopenic ( cuz it s quantitative disorder with low platelet count ) >> P stands for Purpura ( cuz the usual presentation is purpuric rash ) Etiology >> it s thought to be auto immune with auto antibodies ( IgG, IgM ) that bind with platelet membrane,, signaling them for destruction by macrophages in Spleen.. >> it affects young children more likely.. >> can be divided into *Acute ( last < 6 months,, affect young children ) and *Chronic (last > 6 months,, affect young adults mainly females ).. Clinical presentation ITP >> superficial bleeding ex. Petechia,, epistaxis,, easy bruising.. >> these symptoms usually follow acute viral illness (1-4 weeks after).. >> imp << it s unusual to have splenomegaly Diagnosis >> Diagnosis of exclusion.. >> 1* clinical presentation 2* CBC ( plt count is low,, NL RBC,, NL WBC ),, Bleeding time high 3* Bone Marrow biopsy (we ll notice Increases in Megakaryocyte) it s actually not necessary but can be used to rule out Other Dx ex. Leukemia,, aplastic anemia 8

10 Therapy >> therapy doesn t affect long term outcome of ITP but rather increase plt count in acute conditions.. >> not necessary if plt count >30,000 >> if <30,000 it depends on severity of symptoms :: 1* IVIG ( it has the same effect of steroids but with rapid action >> WE start with it, if it doesn t work start steroids ) 2* Corticosteroids ( before using it U should do BM biopsy to exclude malignancy ex. Leukemia cuz steroids are contraindicated in leukemic patients ) 3* anti-rhd Ig ( for Rh +ve ) these 3 ways can decrease rate of clearance of sensitized platelets rather than decreases antibodies production... 4* Platelets transfusion ( not preferred cuz ITP is autoimmune so Abs can attack the transfused platelets ) used only in sever plt reduction... 5* Splenectomy used in *chronic type,, and *acute type only with life threatening bleeding ( it should be the last modality if previous ways didn t work ) >> 80% resolve in 6 months.. >> 1% can develop Intra Cranial Hemorrhage ICH.. >> Now moving into other Disorders << ** But before that you need to know about what s called MAHA ( Micro Angiopathic Hemolytic Anemia ) and How it Occurs :: It starts with vascular endothelial damage Thrombus formation In this thrombus this will trigger Platelets are consumed Thrombocytopenia Fibrin strands cause mechanical destruction of RBCs passing in that vessel Hemolytic Anemia 9

11 Now this MAHA happens in many conditions like what we re concerned with now >> HUS,, TTP,, DIC <<.. HUS ** H stands for Hemolytic ( hemolytic anemia which is characterized by schistocytes <fragmented RBCs> in Blood film ).. ** U stands for Uremic ( uremia due to acute renal failure that occurs bcz of renal vessels being affected ).. ** S stands for Syndrome.. Etiology >> 90% are caused by E.coli O157:H7 that produces verotoxin which attacks the endothelial lining of renal vessel leading to MAHA.. >> Childhood disease.. Clinical presentation >> Kidney is the main organ involved << >> Bloody Diarrhea.. >> Blood in Urine ( Hematuria ).. >> Signs of ARF ( Acute Renal Failure ).. Tests >> CBC :: platelets,, Hb.. >> Blood film :: schistocytes.. >> their may be Hematuria,, Proteinuria.. Therapy >> often resolves spontaneously.. >> Dialysis might be needed for ARF.. >> Plasma exchange in sever persistent disease.. 10

12 TTP ** Thrombotic Thrombocytopenic Purpura ** Etiology >> Genetic or Acquired deficiency of ADAMTS13 which is protease that normally cleaves multimers of vwf soo.. These multimers causing platelet aggregation, with fibrin strands they cause MAHA.. >> adulthood disease Clinical Presentation >> multiple organs are involved << >> Fever.. >> CNS signs ( seizure,, altered level of consciousness,..) >> signs of renal failure.. >> superficial bleeding.. Tests >> same as HUS Therapy >> TTP is more severe than HUS with higher mortality.. >> it s Hematological Emergency << >> urgent Plasma Exchange may be life saving.. >> steroids,, IVIG,, Splenectomy in non-responders.. 11

13 >> this disease is actually both Platelet & Coagulation disorder << >> it s mostly seen in ICU patients,, usually with shock << Etiology DIC >> their are different causes :: * malignancy.. * sepsis ex. Meningococcemia.. * trauma.. * obstetric events.. **These causes lead to widespread activation of coagulation from the release of procoagulants into circulation leading to :: ** clotting factors consumption & platelets consumption Bleeding anywhere.. ** Fibrin strands in vessels destruct passing RBCs Hemolysis.. ** Fibrinolysis is also activated.. Clinical Presentation >> bleeding and clotting manifestations.. Tests >> platelets >> bleeding time >> PT, PTT >> fibrin degradation products(d-dimer),,>> fibrinogen Therapy **Treatment of DIC is challenging,, what we do is : 1- Treat the underlying cause 2- Replace *Platelets by transfusion *clotting factors by FFP(fresh frozen plasma ) *Fibrinogen by cryoprecipitate 3- using Heparin for thrombosis is controversial 12

14 Now moving into Inherited Qualitative Disorders :: Bernard-soulier (BS) >> autosomal recessive AR >> NL platelet count,, AbNL ADHESION **adhesion occur when platelet bind via it s receptor GP-Ib with vwf ** >> here we have deficiency of GP-Ib... Glanzmann Thrombasthenia (GT) >> NL Platelet count,, NL Adhesion,, AbNL AGGREGATION ** aggregation occur when platelets bind with each other via their receptor GPIIb-IIIa having fibrinogen in between as ligand ** >> here we have deficiency of GPIIb-IIIa... von-willebrand Disease (vwd) >> Deficiency of vwf >> this disease is both Platelet & Coagulation disorder << ** Platelet disorder cuz vwf is part of platelet adhesion process.. ** Coagulation Disorder cuz FVIII is bound with vwf in circulation.. >> it has 3 types :: <> Type 1 <> - Quantitative ( partial reduction ) of vwf - the most common one affecting around 80% - Autosomal Dominant AD - usually asymptomatic <> Type 2 <> - Qualitative defect in vwf ( can t bind FVIII ) - Hemophilia equivalent cuz their will be FVIII deficiency <> Type 3 <> - Quantitative ( absolute reduction ) of vwf - Autosomal Recessive AR - v.low FVIII 13

15 And NOW moving into the LAST PART of the lecture Clinical Presentation ** Deep Bleeding ** >> Hematoma ( bleeding in tissue outside BV ) >> Hemarthrosis ( bleeding in joints ) ** Delayed Bleeding ** due to the compensatory role of Platelets ( primary Homeostasis ) Lab tests we order :: ** PT ( prothrombine time ) : indicates problem in Extrinsic pathway when prolonged ( NL value sec ).. ** aptt ( activated partial thromboplastin time ) : indicates problem in Intrinsic pathway when prolonged ( NL value ).. ** Thrombin time : for the common pathway,, it tests conversion of fibrinogen into fibrin.. COAGULATION DISORDERS 1- Hemophilia A,, B 2- DIC 3- vwd 4- Liver Disease 5- Vitamin K Deficiency 6- Drugs ex. Heparin,, warfarin 14

16 Hemophilia >> vwd is the MOST common inherited bleeding disorder << Where as >> Hemophilia (A+B) is the most common SEVER inherited disorder << Etiology >> Hereditary Deficiency of pro-coagulant proteins :: * F VIII in Hemophilia A * F IX in Hemophilia B >> both are X-Linked disorders >> Males are mainly affected 1 : 5000 in A,, 1 : 25,000 in B >> Female is usually asymptomatic carrier, unless, her father is affected and mother is carrier, turner syndrome (XO), or lionization of chromosome X.. >> Hemophilia A accounts for % of cases >>Severity of disease correlates with Degree of Deficiency :: 1* SEVER :: * <1% of normal factor level * spontaneous bleeding * bleeding with minor trauma * manifest in Infancy 2* MODERATE :: * 1-5 % of normal factor level * bleeding requires moderate trauma 3* MILD :: * 6-40 % of normal factor level * bleeding requires significant trauma * might go undiagnosed many years 15

17 Clinical Presentation >> Deep bleeding :: Hematoma,, Hemarthrosis.. >> Delayed bleeding >> CNS bleeding may occur so should do CT scan.. >> Intra-abdominal bleeding can occur and suspected when patient complains of abdominal pain after minor trauma.. Tests >> aptt will be High >> specific factor assay ( to determine whether F VIII or F IX ) Therapy >> Replacement Therapy << ** in life threatening bleeding :: - level of % of factor is needed ** in mild to moderate bleeding :: - level of 40% of factor VIII is needed - level of % of factor IX is needed *** for << F VIII >> we need 0.5U/Kg to increase the level by 1% Soo... Dose of F VIII = ( Desired level (%) * weight (kg) * 0.5 ) *** for << F IX >> we need 1.5U/Kg to increase the level by 1% Soo... Dose of F IX = ( Desired level (%) * weight (kg) * 1.5 ) 16

18 Vitamin K deficiency :: ** Vit.K is synthesized by Intestinal bacteria.. ** it s imp for clotting factors (10,9,7,2).. ** deficiency due to :: 1- newborn not receiving vit.k 2- malabsorption as in cystic fibrosis 3- medications antagonize vit.k like warfarin Liver Disease :: ** we said earlier that all clotting factors except 8 are synthesized in the liver so both Intrinsic & Extrinsic pathway are affected.. ** PT / INR,, aptt will be high.. ** intrinsic pathway will be mostly affected so PT will be High & INR (PT measured / PT standard ) will be High as well.. **aptt can be slightly high due to F 9 being affected.. FXIII deficiency :: ** bleeding,, but,, ** NL PT,, aptt 17

19 Bleeding after circumcision.. Umbilical bleeding after being detached,, or delayed Bleeding during delivery,, CNS bleeding ( cephalhematoma ).. Family history ex. Hemophilia.. Imp points in HISTORY TAKING when patient comes with bleeding Hematoma after IM injection like when vaccinated.. onset of bleeding : Immediate vs delayed.. Site of bleeding : *superficial :: Epistaxis,, gum bleeding,, bleeding after tooth extraction,, petechia,, purpura.. *deep :: hematoma,, hemarthrosis.. Drug history ex. Aspirin,, warfarin,, heparin.. what about OSCE??! Example :: case of ITP :: U should be able to answer them ^^ >>> 4 YO boy presented by his mother with multiple bruises on lower limbs and elbow >>> Q1 what are the questions you would like to ask?? As in the previous page + ( imp Q ) any recent viral infection?? Q2 what are the signs you would like to examine?? 18

20 Q3 what are your DDx?? And most likely Dx?? Q4 what tests you would like to order?? Q5 if platelets count was 5000,, what s your next step?? Q6 how does IVIG work?? Q7 if IVIG didn t work,, what should you do?? Q8 what test should be done before using steroid?? Why?? Q9 if all didn t work,, what is your final way?? 19

Coagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU

Coagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU Coagulation Disorders Dr. Muhammad Shamim Assistant Professor, BMU 1 Introduction Local Vs. General Hematoma & Joint bleed Coagulation Skin/Mucosal Petechiae & Purpura PLT wound / surgical bleeding Immediate

More information

HEME 10 Bleeding Disorders

HEME 10 Bleeding Disorders HEME 10 Bleeding Disorders When injury occurs, three mechanisms occur Blood vessels Primary hemostasis Secondary hemostasis Diseases of the blood vessels Platelet disorders Thrombocytopenia Functional

More information

Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN

Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN The student should be able:» To identify the mechanism of homeostasis and the role of vessels, platelets

More information

Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College

Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College AN APPROACH TO BLEEDING DISORDERS NORMAL HEMOSTASIS After injury, 3 processes halt bleeding Vasoconstriction

More information

Bleeding Disorders. Dr. Mazen Fawzi Done by Saja M. Al-Neaumy Noor A Mohammad Noor A Joseph Joseph

Bleeding Disorders. Dr. Mazen Fawzi Done by Saja M. Al-Neaumy Noor A Mohammad Noor A Joseph Joseph Bleeding Disorders Dr. Mazen Fawzi Done by Saja M. Al-Neaumy Noor A Mohammad Noor A Joseph Joseph Normal hemostasis The normal hemostatic response involves interactions among: The blood vessel wall (endothelium)

More information

Haemostasis & Coagulation disorders Objectives:

Haemostasis & Coagulation disorders Objectives: Haematology Lec. 1 د.ميسم مؤيد علوش Haemostasis & Coagulation disorders Objectives: - Define haemostasis and what are the major components involved in haemostasis? - How to assess the coagulation status?

More information

Bleeding and Thrombotic Disorders. Kristine Krafts, M.D.

Bleeding and Thrombotic Disorders. Kristine Krafts, M.D. Bleeding and Thrombotic Disorders Kristine Krafts, M.D. Bleeding and Thrombotic Disorders Bleeding disorders von Willebrand disease Hemophilia A and B DIC TTP/HUS ITP Thrombotic disorders Factor V Leiden

More information

Pathology note 8 BLEEDING DISORDER

Pathology note 8 BLEEDING DISORDER Pathology note 8 BLEEDING DISORDER Slide75 ( Types of clotting factors deficiency): Today we will talk about public public factor deficiency it could be acquired or inherited, acquired diseases are more

More information

Bleeding disorders. Hemostatic failure: Inappropriate and excessive bleeding either spontaneous or in response to injury.

Bleeding disorders. Hemostatic failure: Inappropriate and excessive bleeding either spontaneous or in response to injury. 1 Bleeding disorders Objectives: 1. Discuss briefly the physiology of hemostasis. 2. Define the mechanisms of thrombocytopenia and the relative bleeding risk at any given platelet count. 3. Be able to

More information

Easy Bleeding General Presentation

Easy Bleeding General Presentation Easy Bleeding General Presentation It is not uncommon for children to bleed and bruise after experiencing trauma. However, a child may also have an underlying coagulopathy, which results in easy and possibly

More information

Platelet Disorders. By : Saja Al-Oran

Platelet Disorders. By : Saja Al-Oran Platelet Disorders By : Saja Al-Oran Introduction The platelet arise from the fragmentation of the cytoplasm of megakaryocyte in the bone marrow. circulate in the blood as disc-shaped anucleate particles

More information

Haemorrhagic Disorders. Dr. Bashar Department of Pathology Mosul Medical College

Haemorrhagic Disorders. Dr. Bashar Department of Pathology Mosul Medical College Haemorrhagic Disorders Dr. Bashar Department of Pathology Mosul Medical College Hemorrhagic Disorders These include Disorders of platelets. Disorders of blood vessels. Disorders of coagulation & fibrinolysis.

More information

INHERITED COAGULOPATHY

INHERITED COAGULOPATHY Disorder Etiology Pathophysiology and Presentation Lab Findings and Diagnosis Treatment INHERITED COAGULOPATHY HEMOPHILIA A and B Hemophilia A: deficiency in XIII (85%) Hemophilia B: deficiency in IX (15%)

More information

Primary Exam Physiology lecture 5. Haemostasis

Primary Exam Physiology lecture 5. Haemostasis Primary Exam Physiology lecture 5 Haemostasis Haemostasis Body s response for the prevention and cessation of bleeding. Broadly consists of: Primary Haemostasis - vascular spasm and platlet plug formation

More information

Hemostatic System - general information

Hemostatic System - general information PLATELET DISORDERS Hemostatic System - general information Normal hemostatic system vessel wall circulating blood platelets blood coagulation and fibrynolysis Bleeding Diathesis inherited or acquired defects

More information

BLEEDING DISORDERS Simple complement:

BLEEDING DISORDERS Simple complement: BLEEDING DISORDERS Simple complement: 1. Select the statement that describe the thrombocytopenia definition: A. Marked decrease of the Von Willebrandt factor B. Absence of antihemophilic factor A C. Disorder

More information

ACQUIRED COAGULATION ABNORMALITIES

ACQUIRED COAGULATION ABNORMALITIES ACQUIRED COAGULATION ABNORMALITIES ACQUIRED COAGULATION ABNORMALITIES - causes 1. Liver disease 2. Vitamin K deficiency 3. Increased consumption of the clotting factors (disseminated intravascular coagulation

More information

Bleeding Disorders: (Hemorrhagic Diatheses) Tests used to evaluate different aspects of hemostasis are the following:

Bleeding Disorders: (Hemorrhagic Diatheses) Tests used to evaluate different aspects of hemostasis are the following: Bleeding Disorders: (Hemorrhagic Diatheses) Excessive bleeding can result from: 1. Increased fragility of vessels. 2. Platelet deficiency or dysfunction. 3. Derangement of coagulation. 4. Combinations

More information

HAEMORRHAGIA Bleeding

HAEMORRHAGIA Bleeding HAEMORRHAGIA Bleeding Cassification Size Location pathomechanism Hematoma: external or may be enclosed within a tissue petechiae : 1-2 mm hemorrhages into skin, mucous membranes, or serosal surfaces increased

More information

BLEEDING (PLATELET) DISORDER. IAP UG Teaching slides

BLEEDING (PLATELET) DISORDER. IAP UG Teaching slides BLEEDING (PLATELET) DISORDER 1 APPROACH The initial set of questions should establish the following: (1) the most common site and type of bleeding (e.g., mucocutaneous versus articular or deep muscle),

More information

Easy bruising vs Coagulopathy

Easy bruising vs Coagulopathy Easy bruising vs Coagulopathy Sept. 19, 2015 Lakehead Summer School Chris Hillis, MD MSc FRCPC hillis@hhsc.ca @HemeHillis Aim & Objectives Aim: To increase comfort in detecting non-pathologic bleeding

More information

Bleeding Disorders.2 MS Abdallah Awidi Abbadi.MD. FRCP.FRCPath Feras Fararjeh MD

Bleeding Disorders.2 MS Abdallah Awidi Abbadi.MD. FRCP.FRCPath Feras Fararjeh MD Bleeding Disorders.2 MS4.25.02.2019 Abdallah Awidi Abbadi.MD. FRCP.FRCPath Feras Fararjeh MD Email: abdalla.awidi@gmail.com Case 6: GT 18 yr old female was admitted with pallor, abdominal pain and gum

More information

L iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche

L iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche L iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche Armando Tripodi Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Dept. of Clinical Sciences and Community Health University

More information

Approach to bleeding disorders &treatment. by RAJESH.N General medicine post graduate

Approach to bleeding disorders &treatment. by RAJESH.N General medicine post graduate Approach to bleeding disorders &treatment by RAJESH.N General medicine post graduate 2 Approach to a patient of bleeding diathesis 1. Clinical evaluation: History, Clinical features 2. Laboratory approach:

More information

Approach To A Bleeding Patient

Approach To A Bleeding Patient ABDUL MAJEED, RAHUL RAJEEV REVIEW ARTICLE INTRODUCTION Hemostasis is the process of forming clots in the walls of damaged blood vessels and preventing blood loss while maintaining blood in a fluid state

More information

Congenital bleeding disorders

Congenital bleeding disorders Congenital bleeding disorders Overview Factor VIII von Willebrand Factor Complex factor VIII von Willebrand factor (vwf) complex circulate as a complex + factor IX intrinsic pathway Platelets bind via

More information

LAMA SHATAT TTP, ITP, DIC

LAMA SHATAT TTP, ITP, DIC TTP, ITP, DIC Reduction in platelet number (thrombocytopenia) constitutes an important cause of generalized bleeding. A count less than 100,000 platelets/μl is generally considered to constitute thrombocytopenia.

More information

PCCN Review Hematology

PCCN Review Hematology PCCN Review Hematology Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC CEN, CNRN, CMSRN, NP Education Specialist LRM Consulting Nashville, TN Anemia Definition reduction in RBC concentration Causes iron deficiency

More information

UNIT VI. Chapter 37: Platelets Hemostasis and Blood Coagulation Presented by Dr. Diksha Yadav. Copyright 2011 by Saunders, an imprint of Elsevier Inc.

UNIT VI. Chapter 37: Platelets Hemostasis and Blood Coagulation Presented by Dr. Diksha Yadav. Copyright 2011 by Saunders, an imprint of Elsevier Inc. UNIT VI Chapter 37: Platelets Hemostasis and Blood Coagulation Presented by Dr. Diksha Yadav Hemostasis: Prevention of Blood Loss Vascular constriction Formation of a platelet plug Formation of a blood

More information

This slide belongs to iron lecture and it is to clarify the iron cycle in the body and the effect of hypoxia on erythropoitein secretion

This slide belongs to iron lecture and it is to clarify the iron cycle in the body and the effect of hypoxia on erythropoitein secretion This slide belongs to iron lecture and it is to clarify the iron cycle in the body and the effect of hypoxia on erythropoitein secretion Topics of today lectures: Hemostasis Meaning of hemostasis Mechanisms

More information

Sysmex Educational Enhancement and Development No

Sysmex Educational Enhancement and Development No SEED Coagulation Sysmex Educational Enhancement and Development No 2 2016 An approach to the bleeding patient The purpose of this newsletter is to provide an overview of the approach to the bleeding patient

More information

Chapter 19. Hemostasis

Chapter 19. Hemostasis Chapter 19 Hemostasis Hemostasis Hemostasis is the cessation of bleeding stopping potentially fatal leaks important in small blood vessels not effective in hemorrhage excessive bleeding from large blood

More information

Disseminated Intravascular Coagulation. M.Bahmanpour MD Assistant professor IUMS

Disseminated Intravascular Coagulation. M.Bahmanpour MD Assistant professor IUMS به نام خدا Disseminated Intravascular Coagulation M.Bahmanpour MD Assistant professor IUMS Algorithm for Diagnosis of DIC DIC Score factor score Presence of known underlying disorder No= 0 yes=2 Coagolation

More information

Topics of today lectures: Hemostasis

Topics of today lectures: Hemostasis Topics of today lectures: Hemostasis Meaning of hemostasis Mechanisms of hemostasis - Vascular contraction - Platelets plug - Blood coagulation (clotting) - Structure and functions of platelets - Blood

More information

EDUCATIONAL COMMENTARY PLATELET DISORDERS

EDUCATIONAL COMMENTARY PLATELET DISORDERS EDUCATIONAL COMMENTARY PLATELET DISORDERS Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click on Earn

More information

Introduction to coagulation and laboratory tests

Introduction to coagulation and laboratory tests Introduction to coagulation and laboratory tests Marc Jacquemin Special Haemostasis Laboratory Center for Molecular and Vascular Biology University of Leuven Coagulation in a blood vessel: fibrin stabilises

More information

HAEMORRHAGIA Bleeding

HAEMORRHAGIA Bleeding HAEMORRHAGIA Bleeding Cassification Size Location pathomechanism Hematoma: external or may be enclosed within a tissue petechial rash (spot) : 1-2 mm hemorrhages into skin, mucous membranes, or serosal

More information

Moath Darweesh. Omar Sami. Saleem Khreisha. 1 P a g e

Moath Darweesh. Omar Sami. Saleem Khreisha. 1 P a g e 7 Moath Darweesh Omar Sami Saleem Khreisha 1 P a g e -First of all, I want to give a quick revision to simplify the whole hemostasis mechanism, it will be much easier here with me. Enjoy (you can skip

More information

Hemostasis. Learning objectives Dr. Mária Dux. Components: blood vessel wall thrombocytes (platelets) plasma proteins

Hemostasis. Learning objectives Dr. Mária Dux. Components: blood vessel wall thrombocytes (platelets) plasma proteins Hemostasis Learning objectives 14-16 Dr. Mária Dux Components: blood vessel wall thrombocytes (platelets) plasma proteins Hemostatic balance! procoagulating activity anticoagulating activity 1 Thrombocytes

More information

Coagulation an Overview Dr.Abdolreza Abdolr Afrasiabi Thal assem a & Heamophili hilia G ene i tic R esearc C en er Shiraz Medical Medic University

Coagulation an Overview Dr.Abdolreza Abdolr Afrasiabi Thal assem a & Heamophili hilia G ene i tic R esearc C en er Shiraz Medical Medic University In The Name God Coagulation an Overview Dr.Abdolreza Afrasiabi Thalassemia & Heamophilia Genetic Research hcenter Shiraz Medical University Bleeding Clotting Hemostasis Review of platelet function Platelets

More information

Approach to bleeding

Approach to bleeding Approach to bleeding By Assoc. Prof. Darintr Sosothikul, MD Pediatric Hematology-Oncology division, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University The mechanism of

More information

Heme (Bleeding and Coagulopathies) in the ICU

Heme (Bleeding and Coagulopathies) in the ICU Heme (Bleeding and Coagulopathies) in the ICU General Topics To Discuss Transfusions DIC Thrombocytopenia Liver and renal disease related bleeding Lack of evidence in managing critical illness related

More information

There are two main causes of a low platelet count

There are two main causes of a low platelet count Thrombocytopenia Thrombocytopenia is a condition in which a person's blood has an unusually low level of platelets Platelets, also called thrombocytes, are found in a person's blood along with red blood

More information

Blood coagulation and fibrinolysis. Blood clotting (HAP unit 5 th )

Blood coagulation and fibrinolysis. Blood clotting (HAP unit 5 th ) Blood coagulation and fibrinolysis Blood clotting (HAP unit 5 th ) Vessel injury Antithrombogenic (Favors fluid blood) Thrombogenic (Favors clotting) 3 Major systems involved Vessel wall Endothelium ECM

More information

The LaboratoryMatters

The LaboratoryMatters Laboratory Medicine Newsletter for clinicians, pathologists & clinical laboratory technologists. A Initiative. HEMOSTASIS AND THE LABORATORY This issue highlights: Primary Hemostasis Screening Tests Case

More information

Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89

Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89 Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89 Presented by Jennifer Kurkulonis 1 FOUR MAJOR TYPES OF BLOOD CELLS White blood cells

More information

Ch. 45 Blood Plasma proteins, Coagulation and Fibrinolysis Student Learning Outcomes: Describe basic components of plasma

Ch. 45 Blood Plasma proteins, Coagulation and Fibrinolysis Student Learning Outcomes: Describe basic components of plasma Chapt. 45 Ch. 45 Blood Plasma proteins, Coagulation and Fibrinolysis Student Learning Outcomes: Describe basic components of plasma Inheritance of X-linked gene for Factor VIII hemophilia A Explain the

More information

Document Title: Hemostasis: Platelet and Coagulation Disorders. Author(s): Joseph H. Hartmann (University of Michigan), DO 2012

Document Title: Hemostasis: Platelet and Coagulation Disorders. Author(s): Joseph H. Hartmann (University of Michigan), DO 2012 Project: Ghana Emergency Medicine Collaborative Document Title: Hemostasis: Platelet and Coagulation Disorders Author(s): Joseph H. Hartmann (University of Michigan), DO 2012 License: Unless otherwise

More information

Blood clotting. Subsequent covalent cross-linking of fibrin by a transglutaminase (factor XIII) further stabilizes the thrombus.

Blood clotting. Subsequent covalent cross-linking of fibrin by a transglutaminase (factor XIII) further stabilizes the thrombus. Blood clotting It is the conversion, catalyzed by thrombin, of the soluble plasma protein fibrinogen (factor I) into polymeric fibrin, which is deposited as a fibrous network in the primary thrombus. Thrombin

More information

The importance of thrombocytopenia and its causes

The importance of thrombocytopenia and its causes SYSMEX EDUCATIONAL ENHANCEMENT AND DEVELOPMENT NO 4 2017 SEED HAEMATOLOGY The importance of thrombocytopenia and its causes Key words: Thrombocytopenia, thrombocytopenic, low levels of platelets What is

More information

What is meant by Thrombotic Microangiopathy (TMA)?

What is meant by Thrombotic Microangiopathy (TMA)? What is meant by Thrombotic Microangiopathy (TMA)? Thrombotic Microangiopathy (TMA) is a group of disorders characterized by injured endothelial cells, microangiopathic hemolytic anemia (MAHA), with its

More information

Thrombotic Thrombocytopenic Purpura and the Role of ADAMTS-13

Thrombotic Thrombocytopenic Purpura and the Role of ADAMTS-13 Thrombotic Thrombocytopenic Purpura and the Role of ADAMTS-13 Mark Cunningham,MD Director, Hematology Laboratory Department of Pathology University of Kansas Medical Center College of American Pathologists

More information

The Child with a Hematologic Alteration

The Child with a Hematologic Alteration 47 The Child with a Hematologic Alteration HELPFUL HINT Review the anatomy and physiology of the hematologic system in an anatomy and physiology textbook. MATCHING KEY TERMS Match the term with the correct

More information

Bleeding and Haemostasis. Saman W.Boskani HDD, FIBMS Maxillofacial Surgeon

Bleeding and Haemostasis. Saman W.Boskani HDD, FIBMS Maxillofacial Surgeon Bleeding and Haemostasis Saman W.Boskani HDD, FIBMS Maxillofacial Surgeon 1 Beeding Its escaping or extravasation of blood contents from blood vessels Types: - Arterial - Venous - Capillary Differences

More information

Acute Immune Thrombocytopenic Purpura (ITP) in Childhood

Acute Immune Thrombocytopenic Purpura (ITP) in Childhood Acute Immune Thrombocytopenic Purpura (ITP) in Childhood Guideline developed by Robert Saylors, MD, in collaboration with the ANGELS team. Last reviewed by Robert Saylors, MD September 22, 2016. Key Points

More information

Y. Helen Zhang, MD Andy Nguyen, MD 10/28/2012

Y. Helen Zhang, MD Andy Nguyen, MD 10/28/2012 Y. Helen Zhang, MD Andy Nguyen, MD 10/28/2012 Clinical History Patient: 23-year-old female Clinical course: status-post cholecystectomy, complicated by retained common bile duct stones. Following three

More information

Part IV Antithrombotics, Anticoagulants and Fibrinolytics

Part IV Antithrombotics, Anticoagulants and Fibrinolytics Part IV Antithrombotics, Anticoagulants and Fibrinolytics "The meaning of good and bad, of better and worse, is simply helping or hurting" Emerson Chapter 16: Blood Coagulation and Fibrinolytic System

More information

Thursday, February 26, :00 am. Regulation of Coagulation/Disseminated Intravascular Coagulation HEMOSTASIS/THROMBOSIS III

Thursday, February 26, :00 am. Regulation of Coagulation/Disseminated Intravascular Coagulation HEMOSTASIS/THROMBOSIS III REGULATION OF COAGULATION Introduction HEMOSTASIS/THROMBOSIS III Regulation of Coagulation/Disseminated Coagulation necessary for maintenance of vascular integrity Enough fibrinogen to clot all vessels

More information

COAGULATIONS. Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin)

COAGULATIONS. Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin) COAGULATIONS Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin) Haemostasis-blood must be maintained in a fluid state in order to function as a transport system, but must be able to solidify to form a clot following

More information

BLEEDING DISORDERS. JC Opperman 2012

BLEEDING DISORDERS. JC Opperman 2012 BLEEDING DISORDERS JC Opperman 2012 Primary and Secondary Clotting Laboratory Tests Routine screening tests Prothrombin time (PT) (INR) increased in neonates (12-18 sec) Partial thromboplastin time (PTT)

More information

Hemostasis. Clo)ng factors and Coagula4on NORMAL COAGULATION. Overview of blood coagula4on. The Cascade Theory 5/1/12. Clot

Hemostasis. Clo)ng factors and Coagula4on NORMAL COAGULATION. Overview of blood coagula4on. The Cascade Theory 5/1/12. Clot Hemostasis Clo)ng factors and Coagula4on Dr Badri Paudel www.badripaudel.com Hemostasis is defined as a property of circula4on whereby blood is maintained within a vessel and the ability of the system

More information

What are blood clots?

What are blood clots? What are blood clots? Dr Matthew Fay GP Principal The Willows Medical Practice- Queensbury GPwSI and Co-Founder Westcliffe Cardiology Service GP Partner Westcliffe Medical Group Created 5/31/18 Dr. Matthew

More information

John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne

John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne Overview of coagulation Testing coagulation Coagulopathy in ICU Incidence Causes Evaluation Management Coagulation

More information

Chapter 11. Lecture and Animation Outline

Chapter 11. Lecture and Animation Outline Chapter 11 Lecture and Animation Outline To run the animations you must be in Slideshow View. Use the buttons on the animation to play, pause, and turn audio/text on or off. Please Note: Once you have

More information

Blood Transfusion Guidelines in Clinical Practice

Blood Transfusion Guidelines in Clinical Practice Blood Transfusion Guidelines in Clinical Practice Salwa Hindawi Director of Blood Transfusion Services Associate Professor in Haematology and Transfusion Medicine King Abdalaziz University, Jeddah Saudi

More information

General approach to the investigation of haemostasis. Jan Gert Nel Dept. of Haematology University of Pretoria 2013

General approach to the investigation of haemostasis. Jan Gert Nel Dept. of Haematology University of Pretoria 2013 General approach to the investigation of haemostasis Jan Gert Nel Dept. of Haematology University of Pretoria 2013 Clinical reasons to investigate haemostasis Investigating a clinically suspected bleeding

More information

-Hashim ahmed is the one who wrote this sheet. I just edited it according to our record.

-Hashim ahmed is the one who wrote this sheet. I just edited it according to our record. * Subjects of this lecture : - Hemostasis - Platelets, general information, their ultrastructure and role in hemostasis. - Definitions: Thrombus, Embolus, Arteriosclerosis and Atherosclerosis. *NOTE: Prof

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,800 116,000 120M Open access books available International authors and editors Downloads Our

More information

Effective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature)

Effective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature) 1 of 5 Policy #: 702 (PHL-702-05) Effective Date: 9/30/2004 Reviewed Date: 8/1/2016 Subject: TRANSFUSION GUIDELINES Approved by: Laboratory Director, Jerry Barker (electronic signature) Approved by: Laboratory

More information

Hematologic Disorders. Assistant professor of anesthesia

Hematologic Disorders. Assistant professor of anesthesia Preoperative Evaluation Hematologic Disorders Dr M.Razavi Assistant professor of anesthesia Anemia Evaluation needs to consider the extent and type of surgery, the anticipated blood loss, and the patient's

More information

The Bleeding Patient. Sarah Stacey Charlotte Maxeke Johannesburg Hospital University of the Witwatersrand

The Bleeding Patient. Sarah Stacey Charlotte Maxeke Johannesburg Hospital University of the Witwatersrand The Bleeding Patient Sarah Stacey Charlotte Maxeke Johannesburg Hospital University of the Witwatersrand The Bleeding Patient If you prick us, do we not bleed? Disorders of secondary homeostasis: dysfunction

More information

Agent Dose MoA/PK/Admin Adverse events Disadvantages Protamine Heparin: 1mg neutralizes ~ 100 units Heparin neutralization in ~ 5 min

Agent Dose MoA/PK/Admin Adverse events Disadvantages Protamine Heparin: 1mg neutralizes ~ 100 units Heparin neutralization in ~ 5 min Nanik (Nayri) Hatsakorzian Pharm.D/MPH candidate 2014 Touro University College of Pharmacy CA Bleeding Reversal Agents Agent Dose MoA/PK/Admin Adverse events Disadvantages Protamine Heparin: 1mg neutralizes

More information

Guidelines for Shared Care Centres and Community Staff

Guidelines for Shared Care Centres and Community Staff Reference: CG1410 Written by: Dr Jeanette Payne Peer reviewer Dr Jenny Welch Approved: February 2016 Approved by D&TC: 8th January 2016 Review Due: February 2019 Intended Audience This document contains

More information

Coagulation, Haemostasis and interpretation of Coagulation tests

Coagulation, Haemostasis and interpretation of Coagulation tests Coagulation, Haemostasis and interpretation of Coagulation tests Learning Outcomes Indicate the normal ranges for routine clotting screen and explain what each measurement means Recognise how to detect

More information

Diagnosis of hypercoagulability is by. Molecular markers

Diagnosis of hypercoagulability is by. Molecular markers Agenda limitations of clinical laboratories to evaluate hypercoagulability and the underlying cause for thrombosis what is the INR the lupus anticoagulant and the antiphospholipid antibody syndrome hassouna

More information

Disseminated Intravascular Coagulation (DIC) Seminar. Ron Kopilov 4 th year Medical Student, Tel Aviv University Internal Medicine A 8.3.

Disseminated Intravascular Coagulation (DIC) Seminar. Ron Kopilov 4 th year Medical Student, Tel Aviv University Internal Medicine A 8.3. Disseminated Intravascular Coagulation (DIC) Seminar Ron Kopilov 4 th year Medical Student, Tel Aviv University Internal Medicine A 8.3.2012 1 Our plan: Understand the pathophysiology Identify risk factors

More information

Approach to disseminated intravascular coagulation

Approach to disseminated intravascular coagulation Approach to disseminated intravascular coagulation Khaire Ananta Shankarrao 1, Anil Burley 2, Deshmukh 3 1.MD Scholar, [kayachikitsa] 2.Professor,MD kayachikitsa. 3.Professor and HOD,Kayachikitsa. CSMSS

More information

Physiology of. The Blood hemostasis. By prof. Israa f. jaafar

Physiology of. The Blood hemostasis. By prof. Israa f. jaafar Physiology of The Blood hemostasis By prof. Israa f. jaafar Learning objectives Understand the Platelet structure and function Explane the Platelet production Understand the phases of hemostasis: vascular

More information

Platelet vs. Coagulation Bleeding. Qualitative and Quantitative Platelet Disorders. Laboratory Tests. Platelet Signaling. Jeffrey S. Jhang, M.D.

Platelet vs. Coagulation Bleeding. Qualitative and Quantitative Platelet Disorders. Laboratory Tests. Platelet Signaling. Jeffrey S. Jhang, M.D. Qualitative and Quantitative Platelet isorders Platelet vs. Coagulation Bleeding Findings Petechiae Hematomas and Hemarthroses elayed Bleeding Coagulation Rare Common Common Platelet Common Rare Rare Bleeding

More information

Bleeding Disorders.1 MS4.24.Feb.19. Abdallah Awidi Abbadi.MD. FRCP.FRCPath Professor

Bleeding Disorders.1 MS4.24.Feb.19. Abdallah Awidi Abbadi.MD. FRCP.FRCPath Professor Bleeding Disorders.1 MS4.24.Feb.19 Abdallah Awidi Abbadi.MD. FRCP.FRCPath Professor Email: abdalla.awidi@gmail.com Hemostasis BV Injury Neural Contact Damage/contact. Blood Vessel Constriction Reduced

More information

DIC. Bert Vandewiele Fellow Critical Care 23 May 2011

DIC. Bert Vandewiele Fellow Critical Care 23 May 2011 DIC Bert Vandewiele Fellow Critical Care 23 May 2011 Dissiminated Intravascular Coagulopathie 11/3/2011 Dr. Bert Vandewiele 2 Dissiminated Intravascular Coagulopathie = Consumption coagulopathie = Defibrination

More information

Routine preoperative coagulation tests: are they necessary?

Routine preoperative coagulation tests: are they necessary? Routine preoperative coagulation tests: are they necessary? Dr Azzah Alzahrani MD Pediatrics Hematology /Oncology PSMMS Outline Introduction. Brief review of hemostatic mechanisms. A clinical aspect of

More information

Blood Lecture Test Questions Set 2 Summer 2012

Blood Lecture Test Questions Set 2 Summer 2012 Blood Lecture Test Questions Set 2 Summer 2012 1. Leukocytes are attracted to a site of injury or disease by: a. diapedesis b. chemotaxis c. leukocytosis d. heparin e. leukomotosis 2. Leukocytes leave

More information

Miss. kamlah ahmed 1

Miss. kamlah ahmed 1 Miss. kamlah ahmed 1 Anatomy & Physiology Blood has two compartments: 1- a fluid portion called plasma. 2- a cellular portion known as the formed elements of the blood. Which are RBC (erythrocytes), WBC

More information

Hemolytic uremic syndrome: Investigations and management

Hemolytic uremic syndrome: Investigations and management Hemolytic uremic syndrome: Investigations and management SAWAI Toshihiro M.D., Ph.D. Department of Pediatrics, Shiga University of Medical Science Otsu, JAPAN AGENDA TMA; Thrombotic micro angiopathy STEC-HUS;

More information

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi Anemia (3).ms4.25.Oct.15 Hemolytic Anemia Abdallah Abbadi Case 3 24 yr old female presented with anemia syndrome and jaundice. She was found to have splenomegaly. Hb 8, wbc 12k, Plt 212k, retics 12%, LDH

More information

Chapter 19 Blood Lecture Outline

Chapter 19 Blood Lecture Outline Chapter 19 Blood Lecture Outline Cardiovascular system Circulatory system Blood 1. distribution 2. regulation 3. protection Characteristics: ph 7.4 38 C 4-6 L Composition: Plasma Formed elements Erythrocytes

More information

HEMOSTASIS/THROMBOSIS II

HEMOSTASIS/THROMBOSIS II HEMOSTASIS/THROMBOSIS II Congenital/Acquired Hemorrhagic Disorders & Their Treatment COAGULATION TESTING!Bleeding time primary screening test for platelet function!if bleeding time abnormal!platelet Aggregation

More information

Hematologic changes in systemic diseases. Chittima Sirijerachai

Hematologic changes in systemic diseases. Chittima Sirijerachai Hematologic changes in systemic diseases Chittima Sirijerachai Systemic diseases Infection Renal diseases Liver diseases Connective tissue diseases Malignancy Anemia of chronic disease (ACD) Chronic infections:

More information

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust Regional Paediatric Specialty Trainees teaching 4 th July 2017 Scope

More information

Hemodynamic Disorders, Thrombosis, and Shock. Richard A. McPherson, M.D.

Hemodynamic Disorders, Thrombosis, and Shock. Richard A. McPherson, M.D. Hemodynamic Disorders, Thrombosis, and Shock Richard A. McPherson, M.D. Edema The accumulation of abnormal amounts of fluid in intercellular spaces of body cavities. Inflammation and release of mediators

More information

Most Common Hemostasis Consults: Thrombocytopenia

Most Common Hemostasis Consults: Thrombocytopenia Most Common Hemostasis Consults: Thrombocytopenia Cindy Neunert, MS MSCS Assistant Professor, Pediatrics CUMC Columbia University TSHNA Meeting, April 15, 2016 Financial Disclosures No relevant financial

More information

Contemporary perspectives and initial management of pediatric ITP. William Beau Mitchell, MD Weill Cornell Medical College New York, NY USA

Contemporary perspectives and initial management of pediatric ITP. William Beau Mitchell, MD Weill Cornell Medical College New York, NY USA Contemporary perspectives and initial management of pediatric ITP William Beau Mitchell, MD Weill Cornell Medical College New York, NY USA Case Presentation 5 year old female Bruises on trunk, extremities

More information

LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA Transfusion Criteria Version#2 POLICY NO.

LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA Transfusion Criteria Version#2 POLICY NO. LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA 1011.02 Transfusion Criteria Version#2 Department POLICY NO. PAGE NO. Blood Bank Quality Assurance Manual

More information

Thrombosis. Jeffrey Jhang, M.D.

Thrombosis. Jeffrey Jhang, M.D. Thrombosis Jeffrey Jhang, M.D. Introduction The human hemostatic system has evolved to maintain blood flow under normal physiologic conditions while remaining primed to rapidly respond to vascular injury

More information

MANAGEMENT OF COMMON BLEEDING DISORDERS. Auro Viswabandya Department of Haematology, CMC, Vellore

MANAGEMENT OF COMMON BLEEDING DISORDERS. Auro Viswabandya Department of Haematology, CMC, Vellore MANAGEMENT OF COMMON BLEEDING DISORDERS Auro Viswabandya Department of Haematology, CMC, Vellore BLOOD CLOT : PRIMARY HAEMOSTASIS (Platelets) + SECONDARY HAEMOSTASIS (Coagulation Factors) HAEMOSTATIC DISORDERS

More information

Evaluation Of Bleeding Disorders /AAP Baton Rouge. Raj Warrier

Evaluation Of Bleeding Disorders /AAP Baton Rouge. Raj Warrier Evaluation Of Bleeding Disorders /AAP Baton Rouge Raj Warrier Evaluation and approach to management of a bleeding child Raj Warrier Ochsner /Tulane/LSU Manipal University University Of Queenland Objectives

More information

Pediatric Coagulation Disorders

Pediatric Coagulation Disorders Pediatric Coagulation Disorders Vilmarie Rodriguez, MD,* Deepti Warad, MBBS* *Division of Pediatric Hematology-Oncology, Mayo Clinic Children s Center, Mayo Clinic Comprehensive Hemophilia Center, Mayo

More information

CrackCast Episode 7 Blood and Blood Components

CrackCast Episode 7 Blood and Blood Components CrackCast Episode 7 Blood and Blood Components Episode Overview: 1) Describe the 3 categories of blood antigens 2) Who is the universal donor and why? 3) Define massive transfusion 4) List 5 physiologic

More information

Blood. The only fluid tissue in the human body Classified as a connective tissue. Living cells = formed elements Non-living matrix = plasma

Blood. The only fluid tissue in the human body Classified as a connective tissue. Living cells = formed elements Non-living matrix = plasma Blood Blood The only fluid tissue in the human body Classified as a connective tissue Living cells = formed elements Non-living matrix = plasma Blood Physical Characteristics of Blood Color range Oxygen-rich

More information